Skip to main content

Advertisement

Contact Roberta R Alfieri

From: Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines

Contact corresponding author